Canton Strategic Holdings Inc
General ticker "CNTN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $609.2M (TTM average)
Canton Strategic Holdings Inc does not follow the US Stock Market performance with the rate: -15.8%.
Estimated limits based on current volatility of 5.3%: low 1.90$, high 2.11$
Factors to consider:
- Earnings expected soon, date: 2026-11-16 bmo
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.53$, 5.55$]
- 2026-12-31 to 2027-12-31 estimated range: [0.79$, 3.17$]
Financial Metrics affecting the CNTN estimates:
- Negative: with PPE of -0.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: -9.77 < Return on assets ratio (scaled to [-100,100]) of -6.47
- Positive: 68.95 < Shareholder equity ratio, % of 76.65 <= 81.82
- Positive: Interest expense per share per price, % of 0.03 <= 0.18
Short-term CNTN quotes
Long-term CNTN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $9.46MM | $12.43MM | $20.11MM |
| Operating Income | $-9.46MM | $-12.43MM | $-20.11MM |
| Non-Operating Income | $0.14MM | $0.24MM | $-22.00MM |
| Interest Expense | $0.02MM | $0.01MM | $0.03MM |
| R&D Expense | $3.56MM | $6.39MM | $3.07MM |
| Income(Loss) | $-9.32MM | $-12.20MM | $-42.10MM |
| Taxes | $0.00MM | $0.00MM | $-6.19MM |
| Net Income(Loss)* | $-9.32MM | $-12.20MM | $-35.92MM |
| Stockholders Equity | $9.13MM | $1.31MM | $397.93MM |
| Assets | $10.95MM | $3.72MM | $519.15MM |
| Operating Cash Flow | $-7.30MM | $-10.90MM | $-16.13MM |
| Capital expenditure | $0.00MM | $0.00MM | $77.57MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-77.57MM |
| Financing Cash Flow | $11.72MM | $3.53MM | $107.17MM |
| Earnings Per Share** | $-107.08 | $-9.41 | $-1.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.